8-K
filed November 22, 2022, 6:59 PM ET
ticker NUTX
CIK 0001479681
earnings
confidence high
sentiment negative
materiality 0.85
Nutex Health reports Q3 net loss of $422.5M and $100M Lincoln Park equity facility
Nutex Health Inc.
2022-Q3 EPS reported
-$0.67
revenue$165,570,233
- Q3 net revenue $28.4M, down ~76% YoY, including $29M reduction in accounts receivable estimate.
- Net loss attributable to Nutex $422.5M in Q3, driven by $408.5M non-cash goodwill impairment.
- Adjusted EBITDA loss of $15.7M in Q3; positive $18.5M for nine months ended September 30, 2022.
- Net cash from operations $46.1M for nine months; cash and equivalents $36.6M as of Sep 30.
- Entered $100M common stock purchase agreement with Lincoln Park Capital over 36 months, no warrants.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Nutex Health Inc. reported Three months ended September 30, 2022 results: revenue $28.4 million, net income $(422.5) million.
- Period
- Three months ended September 30, 2022
- Revenue
- $28.4 million
- Net income
- $(422.5) million
- Result
- reported results
Exact text from the filing
Financial Highlights for the Three Months Ended September 30, 2022 (Unaudited): • Net revenue of $28.4 million. In the three months ended September 30, 2022, we reduced our estimate of the ultimate amounts of accounts receivable we will collect for prior periods. This change in estimate reduced revenue for the three months ended September 30, 2022 by approximately $29 million. • Net income attributable to Nutex Health of $(422.5) million.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Nutex Health Inc. reported Nine months ended September 30, 2022 results: revenue $165.6 million, net income $(420.4) million.
- Period
- Nine months ended September 30, 2022
- Revenue
- $165.6 million
- Net income
- $(420.4) million
- Result
- reported results
Exact text from the filing
Financial Highlights for the Nine Months Ended September 30, 2022 (Unaudited): • Net revenue of $165.6 million. • Net income attributable to Nutex Health of $(420.4) million.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.